Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse
Running, not enrolling
Conditions studied: Pelvic Organ Prolapse
In brief
Robotic sacrocolpopexy (a procedure for female pelvic organ prolapse) has been demonstrated to have equivalent surgical outcomes to open abdominal sacrocolpopexy and has been previously deemed more cost effective due to the longer hospital course following open procedures. The total cost of these procedures, including all costs of hospitalization as well as costs associated with the 30 days following surgery have previously been evaluated by the investigators. However, previous research is lacking in both the specific cost components that contribute to intraoperative cost of surgery as well as the patient perceived outcomes following these two procedures. This project aims to evaluate the marginal costs of surgery and to survey sacrocolpopexy patients to evaluate their satisfaction with outcomes and surgical scars.
Key facts
- Study ID
- NCT04179955
- Run by
- Mayo Clinic
- People needed
- 80
- Starts
- 2019-12-10
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-03-31
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women ≥ 18 years of age
- Undergoing abdominal or robotic sacrocolpopexy with or without posterior vaginal repairs
- Willing and able to provide signed informed research consent
- Concurrent and prior hysterectomy
You may not qualify if…
- Repeat sacrocolpopexy
- Concurrent sling procedure
- Concurrent Pouch of Douglas repairs
- Concurrent anterior vaginal wall repairs
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.